<?xml version="1.0" encoding="UTF-8"?>
<table-wrap position="float" id="t0005">
 <label>Table 1</label>
 <caption>
  <p>Clinical features, investigations, treatment and outcome of two cases of adenovirus sLRTI.</p>
 </caption>
 <alt-text id="al0015">Table 1</alt-text>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th>Case</th>
    <th>Comorbidities</th>
    <th>Presentation</th>
    <th>Initial blood results</th>
    <th>Radiological findings</th>
    <th>Virology results</th>
    <th>Adenovirus treatment given &amp; AEs</th>
    <th>Outcome</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td>Case 1:
     <break/>35 year old female
    </td>
    <td>Asthmatic, obese, mental illness</td>
    <td>4 day history of URTI and LRTI symptoms
     <break/>
     <break/>Presented in peak influenza season
    </td>
    <td>Lymphopenia, mildly raised CRP
     <break/>
     <break/>No initial renal dysfunction
     <xref rid="tf0005" ref-type="table-fn">a</xref>
    </td>
    <td>CXR: bilateral consolidation, worsening during admission (
     <xref rid="f0005" ref-type="fig">Fig. 1</xref>)
    </td>
    <td>Throat swab: adenovirus PCR positive
     <break/>
     <break/>BAL: adenovirus PCR positive at 5.8 × 10
     <sup>8</sup> gEq/ml
     <break/>
     <break/>EDTA plasma: adenovirus PCR positive at 9.5 × 10
     <sup>6</sup> gEq/ml
     <xref rid="tf0010" ref-type="table-fn">b</xref>
     <break/>
     <break/>Adenovirus species B type 7 by genomic sequencing
    </td>
    <td>Cidofovir – renal impairment requiring RRT
     <break/>
     <break/>Consideration for ECMO but not initiated due to improvement
    </td>
    <td>Decannulated on day 52 and stepped down to ward level care on day 65</td>
   </tr>
   <tr>
    <td>Case 2:
     <break/>73 year old male
    </td>
    <td>Hypertension, nephrolithiasis</td>
    <td>3 day history of generalised and gastrointestinal symptoms
     <break/>
     <break/>Presented outside of influenza season
    </td>
    <td>Lymphopenia, mildly raised CRP
     <break/>
     <break/>No initial renal dysfunction
     <xref rid="tf0005" ref-type="table-fn">a</xref>
    </td>
    <td>CT chest: left-sided pneumonia and bilateral pleural effusions (
     <xref rid="f0005" ref-type="fig">Fig. 1</xref>)
    </td>
    <td>Throat swab: adenovirus PCR positive
     <break/>
     <break/>BAL: adenovirus PCR positive at 7.5 × 10
     <sup>9</sup> gEq/ml
     <break/>
     <break/>EDTA plasma: adenovirus PCR positive at 2.0 × 10
     <sup>6</sup> gEq/ml
     <xref rid="tf0010" ref-type="table-fn">b</xref>
     <break/>
     <break/>Adenovirus species B type 7 by genomic sequencing
    </td>
    <td>Cidofovir – renal impairment requiring RRT
     <break/>
     <break/>IVIG also given
     <break/>
     <break/>Consideration for ECMO but not initiated due to futility.
    </td>
    <td>Died on day 12 due to multi-organ failure</td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <fn>
   <p>
    <bold>Abbreviations</bold>: BBV = blood borne viruses; LRTI = lower respiratory tract infection; HIV, human immunodeficiency virus; CRP = C-reactive protein; CXR = chest radiograph; CT = computed tomography; BAL = bronchoalveolar lavage; RRT = renal replacement therapy; ECMO = extra-corporeal membrane oxygenation; gEq/ml = genome equivalents/millilitre, IVIG = intravenous immunoglobulin; HDU = high dependency unit (Level 2 Care), URTI = upper respiratory tract infection.
   </p>
  </fn>
 </table-wrap-foot>
 <table-wrap-foot>
  <fn id="tf0005">
   <label>a</label>
   <p id="np0005">Other initial blood tests including haemoglobin, platelets, clotting profile, liver function tests, and bone profile were normal.</p>
  </fn>
 </table-wrap-foot>
 <table-wrap-foot>
  <fn id="tf0010">
   <label>b</label>
   <p id="np0010">Full infection screen included blood cultures, legionella/pneumococcal urinary antigens, urine bacterial culture, blood-borne virus (e.g. HIV, Hepatitis B, and Hepatitis C), serum EDTA plasma: EBV PCR (positive in Case 1 at 728 copies gEq/ml and positive Case 2 at 908 copies gEq/ml, log 3), CMV PCR negative in Cases 1 and 2, upper respiratory tract bacterial culture and extended viral PCR panel, sputum microscopy and bacterial culture and extended viral PCR panel (including from BAL samples), faecal bacterial culture and 
    <italic>Clostridium difficile</italic> screening, and resistant organism swabs including VRE and CPE (Case 2 was VRE positive).
   </p>
  </fn>
 </table-wrap-foot>
</table-wrap>
